Paper - WANFANG MED ONLINE

You Position: Home > Paper

Screening and treatment of retinopathy of prematurity: current status, problems and prospects in China

( views:872, downloads:771 )

Author:: No author available

Journal Title:: Chinese Journal of Ocular Fundus Diseases

Issue:: 1

DOI:: 10.3760/cma.j.issn.1005-1015.2012.01.002

Key Word:: 视网膜病,早产儿/诊断;视网膜病,早产儿/药物疗法;激光凝固术;冷冻疗法;Retinopathy of prematurity/diagnosis;Retinopathy of prematurity/drug therapy;Laser coagulation;Cryotherapy;Editorial

Abstract： Early detection and timely treatment hold the key to cure retinopathy of prematurity (ROP).ROP screening is carried out unevenly in China.Examination equipments and personnel experiences are the major factors to constraint ROP screening.In addition to strengthening personnel training,it is necessary to establish a standard guideline and pipeline for ROP consultation and referral. Laser photocoagulation and cryotherapy are the first options for the threshold ROP and Type 1 pre-threshold ROP.Scleral buckling or vitrectomy is needed for advanced ROP when retinal detachment occurs. The clinical efficacy of intravitreal injection of bevacizumab (an anti-vascular endothelial growth factor monoclonal antibody) for severe ROP is encouraging,but needs further verification.Genetic interference and stem cell therapy will be the prosperous futures in the treatment of ROP.The screening and treatment of ROP in China is becoming more common and improved,but it is still a long way to go considering the huge population of China.

Reference

[1]赵培泉,单海冬,程朝晖,等.阈值前病变1型和阈值期早产儿视网膜病变的激光和冷冻治疗[J].2005,(5).
[2]黄欣,赵培泉,单海冬,等.冷凝和巩膜外环扎治疗4期早产儿视网膜病变五例[J].2005,(5).
[3]单海冬,赵培泉,黄欣,等.经双目间接检眼镜激光光凝治疗严重早产儿视网膜病变[J].2008,(1).
[4]宋哲,黎晓新.腺伴随病毒载体介导Kringle5基因治疗早产儿视网膜病变大鼠视网膜新生血管[J].2005,(5).
[5]尹虹,黎晓新,姜燕荣,等.极低体重早产儿视网膜病变的临床研究[J].2005,(5).
[6]尹虹,黎晓新.早产儿视网膜病变全视网膜脱离的玻璃体视网膜手术治疗预后[J].2008,(1).
[7]黄欣,赵培泉,单海冬,等.闭合式三切口玻璃体视网膜手术治疗4期和5期早产儿视网膜病变[J].2008,(1).
[8]张国明,曾键,黄丽娜,等.广角数码儿童视网膜成像系统引导下激光光凝治疗早产儿视网膜病变[J].2008,(1).
[9]Pierce EA.,Robinson GS.,Webb R.,etc.Oligodeoxynucleotides Inhibit Retinal Neovascularization in a Murine Model of Proliferative Retinopathy[J].1996,93(10).
[10]Hirose Tatsuo.Vision in Stage 5 Retinopathy of Prematurity After Retinal Reattachment by Open-Sky Vitrectomy[J].1993.
[11]W R, Green,S N, Key.Senile macular degeneration: a histopathologic study.[J].1977,75.
[12]Capone A,Lai M,Wu WC,etc.Plasmin enzyme-assisted vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity.[J].2008,28(3 Suppl.).
[13]Smith LE,Shen W,Perruzzi C,etc.Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.[J].1999,5(12).
[14]Benjawan, Wutthiworawong,Usa, Thitiratsanont,Chairat, Saovaprut,etc.Combine intravitreal bevacizumab injection with laser treatment for aggressive posterior retinopathy of prematurity (AP-ROP).[J].2011,94 Suppl 3.
[15]Travassos AS,Travassos A,Regadas I,etc.Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity.[J].2007,38(3).
[16]Prenner JL,Capone A Jr,Trese MT.Visual outcomes after lens-sparing vitrectomy for stage 4A retinopathy of prematurity.[J].2004,111(12).
[17]M T, Trese.Scleral buckling for retinopathy of prematurity.[J].1994,101(1).
[18].An International Classification of Retinopathy of Prematurity[J].1984.
[19]Lakhanpal Rohit R..Lens Clarity After 3-Port Lens-Sparing Vitrectomy in Stage 4A and 4B Retinal Detachments Secondary to Retinopathy of Prematurity[J].2006.
[20]de-Juan E Jr,Repka MX,Hinz BJ.Scleral buckling surgery for active stage 4A retinopathy of prematurity.[J].1998,105(10).
[21]Ihara K,Kinukawa N,Hikino S,etc.Physical growth and retinopathy in preterm infants: involvement of IGF-I and GH.[J].2001,50(6).
[22]Trinavarat A,Atchaneeyasakul LO.Choroidal ruptures after adjuvant intravitreal injection of bevacizumab for aggressive posterior retinopathy of prematurity.[J].2010,30(7).
[23].Multicenter Trial of Cryotherapy for Retinopathy of Prematurity[J].1988.
[24].Multicenter Trial of Cryotherapy for Retinopathy of Prematurity[J].1993.
[25]Fortun JA,Chan Kai B,Holz ER,etc.Lensectomy and vitrectomy with and without intravitreal triamcinolone acetonide for vascularly active stage 5 retinal detachments in retinopathy of prematurity.[J].2006,26(7).
[26].Multicenter Trial of Cryotherapy for Retinopathy of Prematurity[J].1996.
[27]Otani A,Friedlander M,Kinder K,etc.Bone marrow#150; derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis.[J].2002,8(9).
[28]TATSUHIKO SATO,KAZUKO WADA,HITOMI ARAHORI,etc.Serum Concentrations of Bevacizumab (Avastin) and Vascular Endothelial Growth Factor in Infants With Retinopathy of Prematurity[J].2012,153(2).
[29]Ando A,Ettyreddy D,Zack DJ,etc.Pigment epithelium-derived factor inhibits retinal and choroidal neovascularization.[J].2001,188(2).
[30]Trese MT,Capone-A Jr.Lens-sparing vitreous surgery for tractional stage 4A retinopathy of prematurity retinal detachments.[J].2001,108(11).
[31]Arnd, Gandorfer.Microplasmin-assisted vitrectomy.[J].2009,44.
[32]Gole GA,Camuglia JE,Ells AL.Bevacizumab for retinopathy of prematurity.[J].2011,364(24).
[33]M T, Trese.Visual results and prognostic factors for vision following surgery for stage V retinopathy of prematurity.[J].1986,93(5).
[34]Negi A,Tsukahara Y,Honda S,etc.Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity.[J].2008,246(7).
[35].Multicenter Trial of Cryotherapy for Retinopathy of Prematurity[J].1990.
[36]A, Hanneken,A, Baird.Soluble forms of the high-affinity fibroblast growth factor receptor in human vitreous fluid.[J].1995,36.
[37]Gilbert CE,Zin A,Darlow B.Bevacizumab for retinopathy of prematurity.[J].2011,364(24).
[38]Kennedy KA,Chuang AZ,Mintz Hittner HA.Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.[J].2011,364(7).
[39]T, Asahara,T, Murohara,A, Sullivan,etc.Isolation of putative progenitor endothelial cells for angiogenesis.[J].1997,275.
[40]L G, Presta,H, Chen,S J, O'Connor,etc.Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.[J].1997,57.
[41]Trese MT,Droste PJ.Long-term postoperative results of a consecutive series of stages 4 and 5 retinopathy of prematurity.[J].1998,105(6).
[42]YUKI FUCHINO,HIDEYUKI HAYASHI,TOSHIHIRO KONO,etc.Long-term Follow-up of Visual Acuity in Eyes With Stage 5 Retinopathy of Prematurity After Closed Vitrectomy[J].1995,120(3).
[43]Craig Greven,William Tasman.Scleral Buckling in Stages 4B and 5 Retinopathy of Prematurity[J].1990,97(6).
[44]Smith LE,Aiello LP,Pierce EA,etc.Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization.[J].1995,92(3).
[45]Good WV,Palmer EA.Bevacizumab for retinopathy of prematurity.[J].2011,364(24).
[46]Burian G,Cherwick DH,Hubbard GB 3rd.Lens-sparing vitrectomy for stage 4 retinopathy of prematurity.[J].2004,111(12).
[47]Gupta A,Vinekar A,Sanghi G,etc.Frequency-doubled Nd:YAG (532 nm green) versus diode laser (810 nm) in treatment of retinopathy of prematurity.[J].2010,94(9).
[48]Graham E. Quinn,Velma Dobson,Charles C. Barr,etc.Visual Acuity of Eyes after Vitrectomy for Retinopathy of Prematurity: Follow-up at 5 1/2 Years[J].1996,103(4).